"Biotie Therapies Corp. and Somaxon Pharmaceuticals, Inc. announced today that Somaxon has exercised its option to license nalmefene in North America. The companies signed a cooperation and option agreement on nalmefene in July 2004."
BioTie Therapies
BioTie Therapies is a drug development biotechnology company with a focus on dependence disorders, inflammatory diseases and thrombosis.
The most advanced drugs in development are nalmefene for alcoholism (phase III) and impulse control disorders (phase II), monoclonal VAP-1 antibody and small molecule VAP-1 SSAO enzyme inhibitor for inflammatory diseases (late preclinical), and recombinant bioheparin for thrombosis (preclinical). The company is also developing a small molecule a2b1-integrin inhibitor for thrombosis and cancer, and has extensive immaterial property rights and how-know on its K5 polysaccharide technology platform to develop carbohydrate based pharmaceuticals.
BioTie?s shares are listed on the Helsinki Exchanges.
http://www.biotie.com/en/
http://www.biotie.com/en/news/
http://www.somaxon.com/
Stock has been around $1.40 and there are 43 889 233 stocks, so it isn't very big company right now. They went +6.6% today.
Thanks
Pet
BioTie Therapies
BioTie Therapies is a drug development biotechnology company with a focus on dependence disorders, inflammatory diseases and thrombosis.
The most advanced drugs in development are nalmefene for alcoholism (phase III) and impulse control disorders (phase II), monoclonal VAP-1 antibody and small molecule VAP-1 SSAO enzyme inhibitor for inflammatory diseases (late preclinical), and recombinant bioheparin for thrombosis (preclinical). The company is also developing a small molecule a2b1-integrin inhibitor for thrombosis and cancer, and has extensive immaterial property rights and how-know on its K5 polysaccharide technology platform to develop carbohydrate based pharmaceuticals.
BioTie?s shares are listed on the Helsinki Exchanges.
http://www.biotie.com/en/
http://www.biotie.com/en/news/
http://www.somaxon.com/
Stock has been around $1.40 and there are 43 889 233 stocks, so it isn't very big company right now. They went +6.6% today.
Thanks
Pet
Last edited:
